TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
CRVO

CervoMed Inc.

Healthcare · Biotechnology

3.00$ +3.1% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow CRVO
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – – – –
– -98.5% +206.5% +168.3% +62.4% -11.3% +5.4% -9.5% -72.0% – – –
– -63.0% – – – – +26.9% +21.9% -62.8% +22.1% +244.9% +3.1%
– – – – – – – – +4,957.1% – – –
– – +112.2% -277.5% – – +47.7% -75.7% +6.6% -168.8% – –
– -20.9% -94.2% +19,111.6% -100.0% – – – – +200.0% +0.0% -100.0%
– – +245.5% -105.3% – – – – -305,993.5% – – –
– – – – – – – – – – – –
– -92.2% -23.5% +1,002.3% -51.0% +62.6% +11.5% +86.1% -100.0% +222,882.3% +316.2% -90.1%
– -101.6% – – -112.3% – -29.9% +333.3% -276.7% – -67.4% -163.3%
– – – – – – – – – – – –

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?